Replies to post #15108 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

IMO, wishful thinking but I'm hopeful it's not all doom and gloom.

However, a reverse split will be disastrous no matter how they package it without a cash cow partner in tow.

POI: These are the current IND requests

Algernon Pharmaceuticals Files U.S. FDA Pre-IND Meeting Request for Ifenprodil Small Cell Lung Cancer Study
September 22, 2021 07:30 ET

Algernon Pharmaceuticals Files U.S. FDA Pre-IND Meeting Request for Ifenprodil Chronic Cough Phase 2 Study
October 08, 2021 07:00 ET

Algernon Files Meeting Request with MHRA for Use of DMT in Phase 1/2a Human Stroke Study
October 13, 2021 07:00 ET

The DMT study is not being processed through the US FDA

The MHRA encourages companies to seek scientific advice before beginning clinical trials in the UK. These meetings are similar to the pre-IND meetings offered by the U.S. Food and Drug Administration. Through this process, the Company will confirm that its chemistry, manufacturing and controls information, pre-clinical data, and Phase 1/2a clinical plans are appropriate for submission of a Clinical Trial Authorisation (CTA) application for a study with DMT in the UK.

Peace,

M$